Dr. Seth P. Finklestein, M.D., is a distinguished neuroscientist, entrepreneur, and clinician who has spent his career bridging the gap between academic discovery and commercial translation. While serving as an Associate Professor at Harvard Medical School and a practicing Neurologist at Massachusetts General Hospital, his foundational research into polypeptide growth factors laid new groundwork for stroke recovery.

​

Driven to bring these discoveries to scale, Dr. Finklestein emerged as a prominent biotech executive. He led major neuroscience initiatives as VP at Viacell, Inc., and drove innovation from the ground up as the Founder and CEO of Biotrofix, Inc. and Recovery Therapeutics, Inc.— spearheading the development of novel stem cell and small-molecule therapies. By balancing frontline clinical practice at MGH with industry leadership, Dr. Finklestein brings a rare, 360-degree perspective to the field, maintaining an unrelenting commitment to transforming the landscape of recovery after stroke, head injury, and other neurological diseases.